142 related articles for article (PubMed ID: 19896518)
21. HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine.
Ovsyannikova IG; Vierkant RA; Pankratz VS; O'Byrne MM; Jacobson RM; Poland GA
Vaccine; 2009 May; 27(25-26):3349-58. PubMed ID: 19200828
[TBL] [Abstract][Full Text] [Related]
22. Antibody response following rubella immunization analyzed by HLA types.
Ishii K; Nakazono N; Sawada H; Wakisaka A; Moriuchi J; Nakai Y; Kano T; Aizawa M
Jpn J Med Sci Biol; 1980 Apr; 33(2):103. PubMed ID: 7412020
[TBL] [Abstract][Full Text] [Related]
23. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.
Dhiman N; Haralambieva IH; Kennedy RB; Vierkant RA; O'Byrne MM; Ovsyannikova IG; Jacobson RM; Poland GA
Immunogenetics; 2010 Apr; 62(4):197-210. PubMed ID: 20217072
[TBL] [Abstract][Full Text] [Related]
24. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.
Ovsyannikova IG; Jacobson RM; Ryan JE; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
Immunogenetics; 2005 Feb; 56(11):798-807. PubMed ID: 15712014
[TBL] [Abstract][Full Text] [Related]
25. HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses.
Ovsyannikova IG; Jacobson RM; Dhiman N; Vierkant RA; Pankratz VS; Poland GA
Virology; 2007 Jul; 364(1):87-94. PubMed ID: 17397893
[TBL] [Abstract][Full Text] [Related]
26. Study of rubella candidate vaccine based on a structurally modified plant virus.
Trifonova EA; Zenin VA; Nikitin NA; Yurkova MS; Ryabchevskaya EM; Putlyaev EV; Donchenko EK; Kondakova OA; Fedorov AN; Atabekov JG; Karpova OV
Antiviral Res; 2017 Aug; 144():27-33. PubMed ID: 28511994
[TBL] [Abstract][Full Text] [Related]
27. HLA-DR antigens and the rubella-specific immune response in man.
Kato S; Muranaka S; Takakura I; Kimura M; Tsuji K
Tissue Antigens; 1982 Feb; 19(2):140-5. PubMed ID: 6808699
[TBL] [Abstract][Full Text] [Related]
28. Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity.
Tosh PK; Kennedy RB; Vierkant RA; Jacobson RM; Poland GA
Viral Immunol; 2009 Dec; 22(6):451-6. PubMed ID: 19951182
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose.
Jacobson RM; Ovsyannikova IG; Vierkant RA; Pankratz VS; Poland GA
Vaccine; 2011 Oct; 29(45):7982-91. PubMed ID: 21872631
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations.
Matter L; Kogelschatz K; Germann D
J Infect Dis; 1997 Apr; 175(4):749-55. PubMed ID: 9086126
[TBL] [Abstract][Full Text] [Related]
31. Humoral immune response after primary rubella virus infection and after vaccination.
Vauloup-Fellous C; Grangeot-Keros L
Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
[TBL] [Abstract][Full Text] [Related]
32. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
Haralambieva IH; Ovsyannikova IG; Kennedy RB; Goergen KM; Grill DE; Chen MH; Hao L; Icenogle J; Poland GA
Vaccine; 2020 Jan; 38(5):1249-1257. PubMed ID: 31732325
[TBL] [Abstract][Full Text] [Related]
33. HLA antigens and responses to rubella vaccination.
Harcourt GC; Best JM; Banatvala JE; Kennedy LA
J Hyg (Lond); 1979 Dec; 83(3):405-12. PubMed ID: 512353
[TBL] [Abstract][Full Text] [Related]
34. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
[TBL] [Abstract][Full Text] [Related]
35. 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.
Haralambieva IH; Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
Hum Immunol; 2010 Apr; 71(4):383-91. PubMed ID: 20079393
[TBL] [Abstract][Full Text] [Related]
36. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination.
Hayney MS; Poland GA; Jacobson RM; Rabe D; Schaid DJ; Jacobsen SJ; Lipsky JJ
Int J Infect Dis; 1998; 2(3):143-6. PubMed ID: 9531660
[TBL] [Abstract][Full Text] [Related]
37. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
[TBL] [Abstract][Full Text] [Related]
38. Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines.
Scepanovic P; Alanio C; Hammer C; Hodel F; Bergstedt J; Patin E; Thorball CW; Chaturvedi N; Charbit B; Abel L; Quintana-Murci L; Duffy D; Albert ML; Fellay J;
Genome Med; 2018 Jul; 10(1):59. PubMed ID: 30053915
[TBL] [Abstract][Full Text] [Related]
39. How to determine protective immunity in the post-vaccine era.
Charlton CL; Lai FY; Dover DC
Hum Vaccin Immunother; 2016 Apr; 12(4):903-6. PubMed ID: 26811063
[TBL] [Abstract][Full Text] [Related]
40. Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors.
Virnik K; Nesti E; Dail C; Hockenbury M; Ni Y; Felber BK; Schief WR; Berkower I
Vaccine; 2017 May; 35(24):3272-3278. PubMed ID: 28483193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
